Enterprise Value
312.4M
Cash
328M
Avg Qtr Burn
-15.72M
Short % of Float
17.71%
Insider Ownership
0.91%
Institutional Own.
-
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EDG-5506 Details Rare diseases, Duchenne muscular dystrophy | Phase 2 Data readout | |
EDG-5506 Details Becker Muscular Dystrophy | Phase 2 Data readout |